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Background: Mutations in the PRRT2 gene have been identified as the major cause of benign familial infantile
epilepsy (BFIE), paroxysmal kinesigenic dyskinesia (PKD) and infantile convulsions with paroxysmal choreoathetosis/
dyskinesias (ICCA). Here, we analyzed the phenotypes and PRRT2 mutations in Chinese families with BFIE and ICCA.
Methods: Clinical data were collected from 22 families with BFIE and eight families with ICCA. PRRT2 mutations
were screened using PCR and direct sequencing.
Results: Ninety-five family members were clinically affected in the 22 BFIE families. During follow-up, two probands
had one seizure induced by diarrhea at the age of two years. Thirty-one family members were affected in the eight
ICCA families, including 11 individuals with benign infantile epilepsy, nine with PKD, and 11 with benign infantile
epilepsy followed by PKD. Two individuals in one ICCA family had PKD or ICCA co-existing with migraine. One
affected member in another ICCA family had experienced a fever-induced seizure at 7 years old. PRRT2 mutations
were detected in 13 of the 22 BFIE families. The mutation c.649_650insC (p.R217PfsX8) was found in nine families.
The mutations c.649delC (p.R217EfsX12) and c.904_905insG (p.D302GfsX39) were identified in three families and one
family, respectively. PRRT2 mutations were identified in all eight ICCA families, including c.649_650insC (p.R217PfsX8),
c.649delC (p.R217EfsX12), c.514_517delTCTG (p.S172RfsX3) and c.1023A > T (X341C). c.1023A > T is a novel mutation
predicted to elongate the C-terminus of the protein by 28 residues.
Conclusions: Our data demonstrated that PRRT2 is the major causative gene of BFIE and ICCA in Chinese families.
Site c.649 is a mutation hotspot: c.649_650insC is the most common mutation, and c.649delC is the second most
common mutation in Chinese families with BFIE and ICCA. As far as we know, c.1023A > T is the first reported
mutation in exon 4 of PRRT2. c.649delC was previously reported in PKD, ICCA and hemiplegic migraine families, but
we further detected it in BFIE-only families. c.904_905insG was reported in an ICCA family, but we identified it in a
BFIE family. c.514_517delTCTG was previously reported in a PKD family, but we identified it in an ICCA family.
Migraine and febrile seizures plus could co-exist in ICCA families.
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Benign familial infantile epilepsy (BFIE), formerly called be-
nign familial infantile seizures (OMIM 605751), is a benign
familial focal epilepsy syndrome [1,2]. It is characterized
by afebrile seizures with onset between 3 and 12 months
of age. Seizures are partial, with or without secondary
generalization, often occur in clusters and usually remit
before 2 years of age. During childhood or adolescence,
family members in BFIE may develop paroxysmal
kinesigenic choreoathetosis or dyskinesias (PKC/D). The
term “infantile convulsions with paroxysmal choreo-
athetosis” (ICCA, OMIM 602066) has been used to de-
scribe the phenotype of infantile convulsions and
paroxysmal dyskinesias (choreoathetosis or dystonia)
co-occurring in the same patient or family [3]. Paroxys-
mal kinesigenic dyskinesia (PKD, OMIM128200) was first
described by Demirkiran, who suggested using the generic
term “dyskinesia”, rather than dystonia, chorea, or chor-
eoathetosis [4]. PRRT2 gene, encoding proline-rich trans-
membrane protein 2, was recently identified as a major
causative gene for BFIE, PKD and ICCA [5-8]. The aim of
this study was to analyze the clinical features and PRRT2
mutations in Chinese families with BFIE and ICCA.
Methods
Patients
This study was approved by the Ethics Committee of
Peking University First Hospital. Written informed con-
sent for publication of their clinical details was obtained
from the patients or their parents in case of minors. We
recruited 22 BFIE families and eight ICCA families with
autosomal dominant inheritance at Peking University First
Hospital from September 2006 to July 2013. Clinical infor-
mation was collected from the probands and their family
members.
The diagnostic criteria for BFIE were as follows [9,10]:
(1) seizure onset between 3 and 12 months; (2) seizures
in clusters; (3) focal seizures with or without secondary
generalization, usually manifesting motor arrest, deviation
of the head and eyes to one side, generalized hypertonia,
cyanosis, and limb jerks; (4) the interictal electroen-
cephalography (EEG) is normal while the ictal EEG
shows abnormalities that may originate from various
cerebral lobes; (5) normal brain imaging; (6) normal
psychomotor development before, during and after the
onset of seizures; (7) family history of seizures (similar
age at onset); (8) good response to treatment and seizures
remitted often before the age of 2 years. A diagnosis of
PKD was determined according to the criteria proposed
by Bruno as follows [11]: (1) age at onset between1 and
20 years; (2) identified kinesigenic trigger for the attacks;
(3) short duration of attacks (<1 minute); (4) no loss of
consciousness or pain during attacks; (5) control of attacks
with phenytoin or carbamazepine; (6) exclusion of otherorganic diseases and normal neurologic examination.
The diagnosis of ICCA was considered according to
Szepetowski if the two clinical manifestations of BFIE
and PKD were present in the same patient or different
family members [3].
Genetic analysis
Blood samples were obtained from the probands and
their family members where possible. Genomic DNA was
extracted from peripheral blood by standard protocols.
Mutation screening of PRRT2 was performed using PCR
and direct sequencing. Primers for PRRT2 (NM_145239.2)
were designed using Primer Premier 5.0 software. The
three coding exons (containing the coding sequence of the
three isoforms of the protein), 5′ untranslated region
(containing exon 1), and their flanking introns of the
PRRT2 gene were sequenced. Primer sequences and an-
nealing temperatures for PCR are available upon request.
Mutations found in a proband were examined for co-
segregation in other family members. The PRRT2 muta-
tions found in the patients were also screened in 100
Chinese unrelated healthy controls. Impact of an amino
acid substitution of missense mutation was predicted by
PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/). Patients
were followed up at a pediatric neurology clinic at our




Among the 22 families with BFIE, 95 family members
were affected. Families with at least two members affected
by benign infantile epilepsy (BIE) were included and the
largest one had 19 affected members over five generations
(Family 1). Family pedigrees of BFIE families with a PRRT2
mutation are shown in Figure 1A and pedigrees of BFIE
families without a PRRT2mutation are shown in Figure 1B.
Among the 22 probands, the age of seizure onset was 3–
11 months (median: 4.5 months). Seizures remitted either
spontaneously or after treatment with antiepileptic drugs.
However, two probands of unrelated families had one
afebrile seizure induced by diarrhea at the age of 2 years.
The age at last follow-up of these two probands was
2 years and 9 months (Family 6: IV-3) and 3 years and
2 months (Family 11: III-1), respectively. In BFIE Family 6,
the proband (IV-3) had seizure onset at 4.5 months of age
and spontaneous remission at the age of 6 months without
antiepileptic treatment, but she had one afebrile seizure at
31 months of age induced by diarrhea, manifesting as eye
deviation to the left side without loss of consciousness,
which lasted about one minute. In BFIE Family 11, the
proband (III-1) had seizure onset at 3 months of age and
remission after treatment with levetiracetam. He had one
afebrile generalized tonic-clonic seizure at 25 months of
Figure 1 (See legend on next page.)
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Figure 1 Pedigrees of the 22 BFIE families and 8 ICCA families. The arrow indicates the proband. An individual with a heterozygous PRRT2
mutation is indicated by m/+, and an individual without a PRRT2 mutation is indicated by +/+. An individual with an asterisk is a patient with
migraine. (A) Pedigrees of families 1-13: thirteen BFIE families with a PRRT2 mutation, (B) Pedigrees of families 14-22: nine BFIE families without
a PRRT2 mutation, (C) Pedigrees of families 23-30: eight ICCA families with a PRRT2 mutation.
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these two probands was normal.
The clinical features of all the BFIE probands and the
detected PRRT2 mutations are summarized in Table 1.
The clinical data of other affected members in BFIE fam-
ilies were also collected but not included in the Table 1,
because for some, a detailed clinical history of infantile sei-
zures could not be obtained. The clinical history of the
other 73 affected relatives were shown in Additional file 1:
Table S1. Families 1–13 were PRRT2 mutation-positive
and Families 14–22 were PRRT2mutation-negative.
ICCA families
The clinical features of the affected members in the
ICCA families and the detected PRRT2 mutations are
summarized in Table 2. In the eight ICCA families, 31
family members were affected, of which 11 individuals
had BIE only, 9 individuals had PKD only, and 11Table 1 Clinical features and PRRT2 mutations in the proband
Family No. Proband Sex Age of seizure onset Age
1 V-15 F 4.5 m
2 V-1 F 5 m
3 IV-9 F 4 m
4 IV-3 F 4.5 m
5 IV-1 F 7 m
6 IV-3 F 4.5 m
7 III-4 F 3.5 m
8 II-3 M 3.5 m
9 III-1 F 5 m
10 III-1 F 3.5 m
11 III-1 M 3 m
12 III-1 M 4 m
13 IV-1 M 6 m
14 IV-20 M 3 m
15 III-1 M 3.5 m
16 III-4 F 6 m
17 III-2 M 4 m
18 III-1 M 4.5 m
19 III-1 M 3 m
20 III-4 F 10 m
21 IV-1 F 11 m
22 IV-1 F 8 m
M: male, F: female, y: years, m: months.individuals had BIE followed by PKD. Pedigrees of ICCA
families are shown in Figure 1C. In Family 23, the phe-
notypes of PKD or ICCA and migraine with aura co-
existed (II-1 and III-1). In Family 27, the proband had a
seizure during fever at 7 years old.
Genetic analysis
BFIE families
In our 22 BFIE families, three truncating mutations in
PRRT2 were identified in 13 of 22 families (Figure 2),
leading to a mutation rate of 59.1%. The mutation
c.649_650insC (p.R217PfsX8) was found in nine BFIE
families (Families 1–9), accounting for 69.2% (9/13) of
BFIE families with a PRRT2 mutation. In four families,
incomplete penetrance was observed (Family 4: II-3,
Family 5: II-2, Family 6: II-3, and Family 8: I-2)
(Figure 1A). The mutation c.649delC was identified in
three BFIE families (Families 10–12). The mutations of 22 BFIE families
at last follow-up Nucleotide change Amino acid change
4y5 m c.649_650insC p.R217PfsX8





















Table 2 Clinical features and PRRT2 mutations in 31 affected members from 8 ICCA families
Infantile convulsions Paroxysmal dyskinesia
















23 I-2 PKD M - - Adolescence SM D 50y* na na
II-1 PKD F - - 10y SM D 65y c.649_650insC p.R217PfsX8
III-1 ICCA F <12 m 24 m 9y SM D 42y c.649_650insC p.R217PfsX8
III-5 ICCA M <12 m 24 m 8y SM D 38y c.649_650insC p.R217PfsX8
IV-1 ICCA M 7 m 12 m 10y SM D/C 11y c.649_650insC p.R217PfsX8
24 II-3 ICCA F <12 m <24 m 7y SM D 34y c.649_650insC p.R217PfsX8
II-6 BIE M <12 m <24 m - - - 33y na na
III-3 ICCA M 6 m 8 m 7y SM C 9y na na
III-4 BIE M 4.5 m 5 m - - - 6 m c.649_650insC p.R217PfsX8
25 I-2 PKD M - - 14y SM C 51y na na
II-1 PKD F - - 12y SM C 29y c.649_650insC p.R217PfsX8
III-1 BIE M 3.5 m 5 m - - - 5.5 m c.649_650insC p.R217PfsX8
26 II-2 PKD M - - 11y SM D 42y c.649delC p.R217EfsX12
III-1 ICCA F 8 m 10 m 8y SM/S D 16y c.649delC p.R217EfsX12
III-2 BIE F 5 m 9 m - - - 14y na na
27 II-2 ICCA M <12 m 24 m 15y SM/S D 50y c.649delC p.R217EfsX12
II-5 PKD F - - 10y SM D 42y na na
III-1 PKD F - - 10y SM D/C 26y c.649delC p.R217EfsX12
III-4 ICCA M 5.5 m 12 m 8y SM/S D/C 13y c.649delC p.R217EfsX12
III-9 PKD F - - 10y SM D 22y na na
IV-5 BIE F 4.5 m 24 m - - - 3y na na
28 II-1 PKD F - - 5y SM C 35y c.649delC p.R217EfsX12
III-1 ICCA M 4 m 4.5 m 5.5y SM, Ex C 12y c.649delC p.R217EfsX12
III-2 BIE F 4 m 5 m - - - 5y c.649delC p.R217EfsX12
29 II-2 ICCA M 4.5 m 12 m 16y SM D 40y* na na
II-4 BIE M <12 m <24 m - - - 36y c.514_517delTCTG p.S172RfsX3
III-2 BIE F 3 m 5 m - - - 5y c.514_517delTCTG p.S172RfsX3
30 II-1 BIE F <12 m <24 m - - - 83y na na
III-7 BIE F 3 m 24 m - - - 50y na na
III-10 ICCA M 3 m 9 m 12y SM D 41y c.1023A > T X341C
IV-5 BIE M 4 m 8 m - - - 3y9m c.1023A > T X341C
PKD: paroxysmal kinesigenic dyskinesias, BIE: benign infantile epilepsy, ICCA: infantile convulsions with paroxysmal choreoathetosis, M: male, F: female, y: years,
m: months, -: negative, SM: sudden movement, S: startle, Ex: exercise, D: dystonia, C: choreoathetosis, na: not available, *deceased.
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BFIE family (Family 13). In this family, incomplete
penetrance was also observed, the proband’s father (III-2)
carried the mutation without seizures.
ICCA families
In the eight ICCA families, four different PRRT2mutations
were identified (Figure 2). The mutation c.649_650insC
(p.R217PfsX8) was identified in three families, one of
whom had ICCA and co-existing migraine (Family 23).The mutation c.649delC (p.R217EfsX12) was found in
three families (Families 26–28) and the mutation
c.514_517delTCTG (p.S172RfsX3) was present in one
family (Family 29). A novel mutation c.1023A > T
(X341C) in exon 4 was found in one ICCA family
(Family 30). This mutation would result in abrogation
of the stop codon and elongation of the peptide by
28 amino acids at the C-terminal. This mutation was
not found in public single nucleotide polymorphism
databases.
Figure 2 Sequencing chromatograms showing the five PRRT2 mutations detected in BFIE or ICCA families, compared with wild-type
traces. The arrow shows the position of the mutation.
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PRRT2 is an important gene recently identified in neuro-
logical paroxysmal disorders. PRRT2 is the major causative
gene of PKD, BFIE, and ICCA [5-8,12-19], and is also
responsible for several familial or sporadic cases with
paroxysmal non-kinesigenic dyskinesia (PNKD), paroxys-
mal exercised-induced dyskinesia (PED), sporadic BIE, and
hemiplegic migraine (HM) [20-24]. In this study, we ob-
served that PRRT2 mutations are also common in Chinese
families with BFIE and ICCA.
Including our mutations, 62 different PRRT2 mutations
have been described in literature in B(F)IE (Additional
file 2: Table S2). To date, 170 BFIE families and 32 spor-
adic BIE cases have been screened for PRRT2 mutations.
PRRT2 mutations were identified in 74.1% (126/170) of
BFIE families and 34.4% (11/32) of sporadic BIE cases
(Additional file 3: Table S3). Fifteen different PRRT2muta-
tions were identified in BFIE or BIE (Additional file 2:Table S2), including two insertion mutations, five deletion
mutations, four missense mutations, one nonsense muta-
tion, and three splice site mutations. References cited in
Additional file 2: Table S2 and Additional file 3: Table S3
were listed in the Additional file 4: Supplemental references.
The mutation rates of PRRT2 in BFIE ranged from 54.5% to
85.7% in previous studies [6,12,17].
Our study provides the first report of the deletion muta-
tion c.649delC and the insertion mutation c.904_905insG
being associated with a phenotype of BFIE only. The
mutation c.649delC has been previously reported in PKD,
ICCA, and HM [13,22,25-27], but not in families with
BFIE. This mutation was observed in our three BFIE
families (Families 10–12). The mutation c.904_905insG
was previously described in one ICCA family [21]. We
detected this mutation in one BFIE family (Family 13).
The most described mutation c.649_650insC is a hotspot
for PRRT2 mutation. This was also present in our BFIE
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positive families. In previous studies, the percentage of
c.649_650insC in BFIE families with a PRRT2 mutation
ranged from 85.7% to 92.9% [6,12,24]. This mutation was
observed mainly with a BFIE, PKD and ICCA phenotype
[6,8,12,13,28,29], and but also in a few familial or sporadic
cases of PNKD, PED, HM and episodic ataxia [20-22].
This site appears to be particularly prone to mutation:
it occurs in a tract of nine cytosines preceded by four
guanines, facilitating the formation of a hairpin loop
and slippage during DNA replication. Besides the deletion
mutation c.649delC and the insertion mutation c.649_
650insC, a nonsense mutation c.649C > T affecting the
same nucleotide has been reported [13,15,25,30-33].
Incomplete penetrance was found in five of our BFIE
families (Families 4, 5, 6, 8 and13). This phenomenon
has also been described in other studies [6,12,28]. It was
reported that a penetrance of PRRT2 mutations in BFIE
was 82% [12].
In our study, two probands of BFIE families experienced
a single diarrhea-induced seizure. We cannot differentiate
whether the late relapse of seizures in these two patients is
a manifestation of convulsions with mild gastroenteritis
(CwG), or the presentation of BFIE itself. CwG is a well-
recognized infant seizure disorder associated with mild
diarrhea. It is characterized by [34]: (1) previously healthy
infants and young children aged 6 months to 3 years hav-
ing afebrile generalized convulsions associated with symp-
toms of gastroenteritis; (2) seizures occuring sometimes
in cluster; (3) normal laboratory examination results in-
cluding electrolytes, blood glucose and cerebrospinal
fluid; (4) normal interictal electroencephalography; and
(5) excellent seizure and developmental outcomes. The
incidence of CwG is thought to be higher in Asian pop-
ulations than in people from Western countries [35-38].
Okumura reported that approximately 10% of children
with BIE experienced CwG [39]. To explore whether
PRRT2 mutations are associated with CwG, several groups
conducted PRRT2 mutation analysis in patients with
CwG, but no PRRT2 mutation was found [18,24,40].
In our study, PRRT2 mutations were present in 59.1%
of Chinese BFIE families, presumably relating to the ethnic
background. For the absence of a mutation in PRRT2
in our remaining nine BFIE families, microdeletion of
the PRRT2 gene or other BFIE-related genes (SCN2A,
KCNQ2, and KCNQ3) should be to be screened [29].
Microdeletions of PRRT2 gene have been found in
sporadic cases of PKD and ICCA [41], and also in one
PKD family [33].
Including our ICCA families, 95 families with ICCA
has been reported (Additional file 3: Table S3). 23 different
PRRT2 mutations have been reported in the ICCA
phenotype (Additional file 2: Table S2): seven insertion
mutations, four deletion mutations, four missensemutations, six nonsense mutations, one splice site mu-
tation, and one microdeletion. Overall, PRRT2 is re-
ported to be mutated in 83.3%-100% of ICCA families
[6,8,18,31], although one study reported that the much
lower rate of 37.5% [17].We reviewed the PRRT2 mutation
rate in BFIE and ICCA families described in literature and
our study (Additional file 3: Table S3), and found that it
was higher (91.6%, 87/95) in ICCA families than in BFIE
families (74.1%, 126/170).
The mutation c.514-517delTCTG has been previously
observed in one family with PKD [5], and we found this
mutation in an ICCA family. The mutation c.649delC has
been reported in one sporadic ICCA case. In our study,
we found three BFIE (Families 10–12) and three ICCA
families (Families 26–28) with this mutation. This suggests
that this mutation is the second most common mutation
in Chinese families with BFIE and ICCA. We identified a
novel stop codon mutation c.1023A > T (X341C) in one
ICCA family. As far as we know, this mutation is the first
reported mutation of PRRT2 exon 4. It is predicted to
change the stop codon into a cysteine, and would intro-
duce a new stop codon after a 28-amino acids elongation
of the C-terminal tail, which forms the extracellular
domain of the PRRT2 protein. Functional studies of this
mutation should be performed in the future.
We observed some uncommon phenotypes in our ICCA
families. Family 23 is an ICCA family with c.649_650insC
mutation. In this family, migraine co-existed with ICCA
in one individual and with PKD in another. Both rela-
tives had the 649_650inC mutation. The phenotype of
migraine (with or without aura) has been reported in
BFIE, PKD or ICCA families with a PRRT2 mutation
[17,19,20,22,33,42,43]. PRRT2 mutation was identified
in one large family with isolated HM [20]. The reported
frequency of migraine among PRRT2 mutation carriers
is significantly higher (27.1%) than in the overall popula-
tion with epilepsy (8%-15%) [19,44]. Therefore, the associ-
ation of migraine with PRRT2 mutation may not be
coincidental. In Family 27, the proband (III-4) with ICCA
also had an episode of febrile seizure (FS) at 7 years old,
conforming to the diagnosis of febrile seizures plus (FS+).
Patients with FS or FS + have been reported in families
with BFIE [12,23,29,40,45], PKD [25,30,46] or ICCA
[15,17,18]. Some carried PRRT2 gene mutations. However,
FS may not be associated with PRRT2 mutations in ICCA
families. For example, PRRT2 mutation did not co-
segregate with FS in a large ICCA family [15]. In a previ-
ously described ICCA family, only two of the four FS
patients had a PRRT2 mutation [18]. FS are more com-
mon in patients with epilepsy than in the general popula-
tion [47]. It is therefore plausible that the occurrence of
febrile seizures in patients with a PRRT2 gene mutation is
not solely caused by this mutation, but by the occurrence
of epilepsy itself. It could also be caused by a mutation in
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ICCA families, paroxysmal dyskinesias are mostly of the
kinesigenic type, but families with PED have also been re-
ported [48]. A phenotype of PED with PRRT2 mutation
has been reported in two Chinese ICCA families [21].
Conclusions
In summary, we confirm that PRRT2 is the major causative
gene for BFIE and ICCA in Chinese families. Site c.649
is a mutation hotspot: c.649_650insC is the most common
mutation, and c.649delC is the second most common
mutation in Chinese families with BFIE and ICCA. We
also report a novel mutation, c.1023A > T (X341C), in
one ICCA family. Migraine with aura and febrile seizures
plus could co-exist in ICCA families.
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